GlassScriptPhysician profile
Marisa Vinas
NPI 1295264877
$2,175.82
in general payments reported to CMS, 2019-2025
11 companies · $72.78 in 2025
The $72.78 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $41.01 · 2020: $62.73 · 2021: $1,345 · 2022: $464 · 2023: $66.51 · 2024: $124 · 2025: $72.78.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $264.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $263.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,112.49 | 2021 | |
| Kerecis Limited | $385.16 | 2021-2022 | |
| Allergan, INC. | $162.50 | 2022 | |
| Medtronic, INC. | $148.35 | 2022 | |
| Avita Medical Americas, LLC | $106.84 | 2024 | |
| Cook Medical LLC | $103.74 | 2019-2020 | |
| Urgo Medical North America, LLC | $42.72 | 2024-2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Integra Lifesciences Corporation | $39.75 | 2023 | Integra, Surgimend, Integra Dermal Regeneration Template |
| Merz North America, INC. | $33.71 | 2025 | |
| Nevro Corp. | $26.76 | 2023 | Senza |
| Revance Therapeutics, INC. | $13.80 | 2025 | Daxxify |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marisa Vinas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.